These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24564245)

  • 1. Mycophenolate mofetil and sirolimus in hepatocyte transplantation in an experimental model of toxic acute liver failure.
    Loukopoulos I; Sfiniadakis I; Pillai A; Konstantoulakis M; Androulakis G; Bonatsos V; Zografos G; Papalois A
    J Invest Surg; 2014 Aug; 27(4):205-13. PubMed ID: 24564245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of mycophenolate mofetil in the experimental allo-transplantation of hepatocytes in rats with fulminant hepatic failure.
    Kontalexis S; Papalois A; Bibidakis E; Gravvanis A; Lykoudis E; Theodossopoulou E; Dimitroulopoulos D; Sfiniadakis I; Prachalias A; Felekouras E; Dedeilias P; Kontogiorgi M; Papadimitriou L; Papadimitriou I
    Transplant Proc; 2004; 36(6):1739-40. PubMed ID: 15350466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental isolation and transplantation of hepatocytes with the use of antibody against interleukin-2 receptor (daclizumab) as immunosuppressive agent.
    Tsiolis I; Papalois A; Loukopoulos I; Gravvanis A; Lykoudis E; Theodossopoulou E; Chairakakis A; Dimitroulopoulos D; Sfiniadakis I; Vassiliou I; Felekouras E; Dedeilias P; Kontogiorgi M; Papadimitriou L; Papadimitriou I
    Transplant Proc; 2005 May; 37(4):1929-30. PubMed ID: 15919507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.
    Reis A; Reinhard T; Sundmacher R; Braunstein C; Godehardt E
    Br J Ophthalmol; 1998 Jun; 82(6):700-3. PubMed ID: 9797676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenotransplantation of hepatocytes in rats with acute liver failure using sirolimus for immunosuppression.
    Lytras D; Papalois A; Tsaroucha AK; Papagoras D; Kyriazanos J; Lambropoulou M; Giannakou N; Galanos A; Simopoulos CE
    J Int Med Res; 2010; 38(2):546-57. PubMed ID: 20515568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.
    El-Agroudy AE; El-Dahshan KF; Wafa EW; Sheashaa HA; Gad ZA; Ismail AM; Shokeir AA; Ghoneim MA
    Nephrology (Carlton); 2009 Apr; 14(2):255-61. PubMed ID: 19017277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival.
    Yang A; Wang B
    Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
    Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation.
    Reis A; Megahed M; Reinhard T; Godehardt E; Spelsberg H; Braunstein C; Sundmacher R
    Transplantation; 2000 Nov; 70(9):1397-401. PubMed ID: 11087159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.
    Chatel MA; Larkin DF
    Am J Ophthalmol; 2010 Aug; 150(2):179-84. PubMed ID: 20570235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.
    Sampaio EL; Pinheiro-Machado PG; Garcia R; Felipe CR; Park SI; Casarini DE; Moreira S; Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Clin Transplant; 2008; 22(2):141-9. PubMed ID: 18339132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK; Hu RH; Lee CJ; Lee PH
    J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.
    Pan H; Wang L; Zhang X; Zhang G; Mai H; Han Y; Guo S
    Transplant Proc; 2008 Jun; 40(5):1714-21. PubMed ID: 18589179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.
    Wang SS; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Ko WJ; Tsao CI; Sun CD
    Transplant Proc; 2008 Oct; 40(8):2607-8. PubMed ID: 18929814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
    Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
    Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.